tiprankstipranks
Holding SBIO?
Track your performance easily

SBIO Price & Analysis

SBIO ETF Chart & Stats

Day’s Range― - ―
52-Week Range$23.16 - $36.45
Previous Close$35.05
VolumeN/A
Average Volume (3M)12.06K
AUM114.30M
NAV36.19
Expense Ratio0.50%
Holdings Count95
Beta1.02
Inception DateDec 31, 2014
0.07 (―)
Shares Outstanding3,550,000
Standard Deviation0.08
10 Day Avg. Volume11,638
30 Day Avg. Volume12,064
Alpha-0.00898

SBIO ETF FAQ

What was SBIO’s price range in the past 12 months?
SBIO lowest ETF price was $23.16 and its highest was $36.45 in the past 12 months.
    What is the AUM of SBIO?
    As of Feb 19, 2024 The AUM of SBIO is 114.30M.
      Is SBIO overvalued?
      According to Wall Street analysts SBIO’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does SBIO pay dividends?
        SBIO pays a Notavailable dividend of $0.07 which represents an annual dividend yield of N/A. See more information on SBIO dividends here
          How many shares outstanding does SBIO have?
          SBIO has 3,550,000 shares outstanding.
            Which hedge fund is a major shareholder of SBIO?
            Currently, no hedge funds are holding shares in SBIO

            SBIO ETF Smart Score

            For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

            Top 10 Holdings

            Name
            Weight %
            Vaxcyte, Inc.
            4.49%
            Cerevel Therapeutics Holdings Inc
            3.71%
            Alkermes plc
            3.29%
            Revolution Medicines, Inc.
            3.01%
            ACADIA Pharmaceuticals Inc.
            2.58%
            Axsome Therapeutics Inc.
            2.44%
            RayzeBio, Inc.
            2.41%
            Xenon Pharmaceuticals
            2.28%
            CymaBay Therapeutics Inc
            2.25%
            Viking Therapeutics
            2.20%
            Total28.66%

            ETF Description

            ALPS Medical Breakthroughs ETF

            SBIO tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials.
            Sector
            Sector
            Asset Class
            Equity
            Region
            North America
            Issuer
            ALPS
            Index Tracked
            S-Network Medical Breakthroughs Index
            Ticker Symbol
            SBIO
            Popular ETFs
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis